Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VISTEON CORP Director's Dealing 2025

Mar 12, 2025

31294_dirs_2025-03-12_0115e95e-dd0d-4909-9312-b39c66902997.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VISTEON CORP (VC)
CIK: 0001111335
Period of Report: 2025-03-10

Reporting Person: Lawande Sachin (Director, CEO and President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-10 Common Stock M 7000 $80.97 Acquired 294596 Direct
2025-03-10 Common Stock S 6932 $87.13 Disposed 287664 Direct
2025-03-10 Common Stock S 68 $87.68 Disposed 287596 Direct
2025-03-10 Common Stock M 20000 $66.98 Acquired 307596 Direct
2025-03-11 Common Stock M 7000 $80.97 Acquired 314596 Direct
2025-03-11 Common Stock S 7000 $86.50 Disposed 307596 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-10 Employee Stock Option (right to buy) $80.97 M 7000 Disposed 2026-03-06 Common Stock (7000) Direct
2025-03-10 Employee Stock Option (right to buy) $66.98 M 20000 Disposed 2027-03-03 Common Stock (20000) Direct
2025-03-11 Employee Stock Option (right to buy) $80.97 M 7000 Disposed 2026-03-06 Common Stock (7000) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.605 - $87.560, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4

F2: The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.